28 related articles for article (PubMed ID: 8938774)
1. The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model.
Enríquez Pérez J; Fritzell S; Kopecky J; Visse E; Darabi A; Siesjö P
Sci Rep; 2019 Apr; 9(1):5632. PubMed ID: 30948731
[TBL] [Abstract][Full Text] [Related]
2. Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain.
Sarkar G; Curran GL; Sarkaria JN; Lowe VJ; Jenkins RB
PLoS One; 2014; 9(5):e97655. PubMed ID: 24847943
[TBL] [Abstract][Full Text] [Related]
3. Biomaterials for the central nervous system.
Zhong Y; Bellamkonda RV
J R Soc Interface; 2008 Sep; 5(26):957-75. PubMed ID: 18477539
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer treatment with a locally insertable controlled release delivery system.
Keskar V; Mohanty PS; Gemeinhart EJ; Gemeinhart RA
J Control Release; 2006 Oct; 115(3):280-8. PubMed ID: 17034891
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer.
Tai YS; Abente FC; Assalia A; Ueda K; Gagner M
JSLS; 2006; 10(2):160-5. PubMed ID: 16882412
[TBL] [Abstract][Full Text] [Related]
7. Local chemotherapy with cisplatin-depot for glioblastoma multiforme.
Sheleg SV; Korotkevich EA; Zhavrid EA; Muravskaya GV; Smeyanovich AF; Shanko YG; Yurkshtovich TL; Bychkovsky PB; Belyaev SA
J Neurooncol; 2002 Oct; 60(1):53-9. PubMed ID: 12416546
[TBL] [Abstract][Full Text] [Related]
8. Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions.
Emerich DF; Snodgrass P; Lafreniere D; Dean RL; Salzberg H; Marsh J; Perdomo B; Arastu M; Winn SR; Bartus RT
Pharm Res; 2002 Jul; 19(7):1052-60. PubMed ID: 12180539
[TBL] [Abstract][Full Text] [Related]
9. Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors.
Emerich DF; Winn SR; Snodgrass P; LaFreniere D; Agostino M; Wiens T; Xiong H; Bartus RT
Pharm Res; 2000 Jul; 17(7):776-81. PubMed ID: 10990194
[TBL] [Abstract][Full Text] [Related]
10. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors.
Emerich DF; Winn SR; Hu Y; Marsh J; Snodgrass P; LaFreniere D; Wiens T; Hasler BP; Bartus RT
Pharm Res; 2000 Jul; 17(7):767-75. PubMed ID: 10990193
[TBL] [Abstract][Full Text] [Related]
11. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
12. Polymers to treat brain tumours.
Brem H
Biomaterials; 1990 Nov; 11(9):699-701. PubMed ID: 2090306
[TBL] [Abstract][Full Text] [Related]
13. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.
Sahu U; Barth RF; Otani Y; McCormack R; Kaur B
J Neuropathol Exp Neurol; 2022 Apr; 81(5):312-329. PubMed ID: 35446393
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intralesionally administered cisplatin-impregnated biodegradable polymer for the treatment of 9L gliosarcoma in the rat.
Lillehei KO; Kong Q; Withrow SJ; Kleinschmidt-DeMasters B
Neurosurgery; 1996 Dec; 39(6):1191-7; discussion 1197-9. PubMed ID: 8938774
[TBL] [Abstract][Full Text] [Related]
15. Intralesionally implanted cisplatin cures primary brain tumor in rats.
Kong Q; Kleinschmidt-Demasters BK; Lillehei KO
J Surg Oncol; 1997 Apr; 64(4):268-73. PubMed ID: 9142181
[TBL] [Abstract][Full Text] [Related]
16. Intralesionally implanted cisplatin plus systemic carmustine for the treatment of brain tumor in rats.
Kong Q; Kleinschmidt-DeMasters BK; Lillehei KO
J Surg Oncol; 1998 Oct; 69(2):76-82. PubMed ID: 9808509
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
